 |
인쇄하기
취소
|
Yuhan set to export Revanex to Indian market
Yuhan Corporation said on July 8 that it signed a licensing agreement with India based Zydus Cadila over the export of its novel acid pump antagonist Revanex (revaprazan) into Indian market.
Under the agreement, Yuhan will supply Revanex tablets over the next 10 years with proper milestone payment and royalties.
Zydus Cadila, a global healthcare provider and one of India’s leading healthc...
Under the agreement, Yuhan will supply Revanex tablets over the next 10 years with proper milestone payment and royalties.
Zydus Cadila, a global healthcare provider and one of India’s leading healthc...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.